Skip to main content

Table 3 Multiple linear regression models with ANP as a dependent variable with adjustment for exenatide concentration

From: Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure

Variable

ß (95 % CI)

P

Adjusted R2

PAP

2.0 (0.3, 3.8)

0.025

0.19

PCWP

4.0 (0.8, 7.3)

0.017

0.22

RAP

5.6 (2.3, 8.9)

0.002

0.38

  1. ß unstandardized regression-coefficient adjusted for exenatide concentration, PAP mean pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, RAP right atrial pressure
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us